Loading
Loading…
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Status |
|---|---|---|
| 1 | Admitted-Fee/PreQual/Technical/Finance | Admitted-Fee/PreQual/Technical/Finance |
| 2 | Admitted-Fee/PreQual/Technical/Finance S 2 GROUND FLOOR OKHLA INDUSTRIAL AREA PHASE II NEW DELHI DELHI 110020 | SOUTH EAST DELHI | DELHI | 110020 | Admitted-Fee/PreQual/Technical/Finance |
| 3 | Admitted-Fee/PreQual/Technical/Finance 1003 1005 VISHAL TOWER DISTRICT CENTRE JANAK PURI NEW DELHI DELHI 110058 | WEST DELHI | DELHI | 110058 | Admitted-Fee/PreQual/Technical/Finance |
Tender Value
₹2 L
Closing Date
31 Oct 2025, 9:30 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
COMMAND HOSPITAL,CC,LUCKNOW
COMMAND HOSPITAL,CC,LUCKNOW
PROCUREMENT OF HOSPITAL MEDICINE
2025_ARMY_736881_1
MSPC/13/CFA-63/RE DRUGS/2025-26
Limited
Drugs and Pharmaceutical Products
Buy
21 days
COMMAND HOSPITAL, CC
AS PER TENDER DOCUMENTS
2 documents required · 2 mandatory
₹0
Exempted
31 Oct 2025
25 Oct 2025
31 Oct 2025
25 Oct 2025
31 Oct 2025
25 Oct 2025
25 Oct 2025 - 31 Oct 2025
NIV/1683Rabies monoclonal Antibodies Containing - (Docaravimub + Micromavimab for antirabies PEP) 1500 IU
Medikon India Private Limited (BID ID -3459563)
SMPL Life Sciences Pvt. Ltd. (BID ID -3464014)
finance_825086.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.21 MB
RFP63.pdf
Tender Documents • 0.60 MB
BOQ_825086.xls
BOQ • 0.37 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .